Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bacterial lysis, autophagy and innate immune responses during adjunctive phage therapy in a child
Ameneh Khatami, Ruby C.Y. Lin, Aleksandra Petrović Fabijan, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 9
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Considerations for the Use of Phage Therapy in Clinical Practice
Gina A. Suh, Thomas P. Lodise, Pranita D. Tamma, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 3
Open Access | Times Cited: 264
Translating phage therapy into the clinic: Recent accomplishments but continuing challenges
Aleksandra Petrović Fabijan, Jonathan R. Iredell, Katarzyna Danis‐Wlodarczyk, et al.
PLoS Biology (2023) Vol. 21, Iss. 5, pp. e3002119-e3002119
Open Access | Times Cited: 66
Pharmacokinetics/pharmacodynamics of phage therapy: a major hurdle to clinical translation
Sue C. Nang, Yu‐Wei Lin, Aleksandra Petrović Fabijan, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 6, pp. 702-709
Open Access | Times Cited: 55
Phage Paride can kill dormant, antibiotic-tolerant cells of Pseudomonas aeruginosa by direct lytic replication
Enea Maffei, Anne-Kathrin Woischnig, Marco Burkolter, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 24
Biological foundations of successful bacteriophage therapy
Carola Venturini, Aleksandra Petrović Fabijan, Alicia Fajardo Lubián, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 7
Open Access | Times Cited: 61
The Safety and Efficacy of Phage Therapy: A Systematic Review of Clinical and Safety Trials
Helen J. Stacey, Steven De Soir, Joshua D. Jones
Antibiotics (2022) Vol. 11, Iss. 10, pp. 1340-1340
Open Access | Times Cited: 58
Compassionate Use of Bacteriophages for Failed Persistent Infections During the First 5 Years of the Israeli Phage Therapy Center
Hadil Onallah, Ronen Hazan, Ran Nir‐Paz, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 5
Open Access | Times Cited: 35
The Future of Clinical Phage Therapy in the United Kingdom
Joshua D. Jones, Clare Trippett, Mehrunisha Suleman, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 721-721
Open Access | Times Cited: 34
The Safety of Bacteriophages in Treatment of Diseases Caused by Multidrug-Resistant Bacteria
Ka Mun Chung, Sue C. Nang, Swee-Seong Tang
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1347-1347
Open Access | Times Cited: 33
Towards Standardization of Phage Susceptibility Testing: The Israeli Phage Therapy Center “Clinical Phage Microbiology”—A Pipeline Proposal
Ortal Yerushalmy, Ron Braunstein, Sivan Alkalay‐Oren, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. Supplement_5, pp. S337-S351
Open Access | Times Cited: 28
Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case series
Hadil Onallah, Ronen Hazan, Ran Nir‐Paz, et al.
Med (2023) Vol. 4, Iss. 9, pp. 600-611.e4
Closed Access | Times Cited: 23
Bacteriophage Therapy and Current Delivery Strategies for Orthopedic Infections: A SCOPING Review
Jason Young, Sang Won Lee, Mohammad Javad Shariyate, et al.
Journal of Infection (2024) Vol. 88, Iss. 3, pp. 106125-106125
Open Access | Times Cited: 8
Pseudomonas aeruginosa Bacteriophages and Their Clinical Applications
Elaheh Alipour-Khezri, Mikael Skurnik, Gholamreza Zarrini
Viruses (2024) Vol. 16, Iss. 7, pp. 1051-1051
Open Access | Times Cited: 8
Revisiting therapeutic options against Resistant Klebsiella Pneumoniae infection: phage therapy is key
Jiabao Xing, Rong-jia Han, Jinxin Zhao, et al.
Microbiological Research (2025), pp. 128083-128083
Closed Access | Times Cited: 1
Emerging antimicrobial therapies for Gram-negative infections in human clinical use
S Hickson, Emma L. Ledger, Timothy J. Wells
npj Antimicrobials and Resistance (2025) Vol. 3, Iss. 1
Open Access | Times Cited: 1
Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trial
Ameneh Khatami, David A. Foley, Morgyn S. Warner, et al.
BMJ Open (2022) Vol. 12, Iss. 12, pp. e065401-e065401
Open Access | Times Cited: 33
Phage Therapy as a Novel Therapeutic for the Treatment of Bone and Joint Infections
Gina A. Suh, Tristan Ferry, Matthew P. Abdel
Clinical Infectious Diseases (2023) Vol. 77, Iss. Supplement_5, pp. S407-S415
Open Access | Times Cited: 22
The dynamic interplay of bacteriophage, bacteria and the mammalian host during phage therapy
Jacopo Marchi, Sophia Zborowsky, Laurent Debarbieux, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 106004-106004
Open Access | Times Cited: 21
Aspects of Phage-Based Vaccines for Protein and Epitope Immunization
Marco Palma
Vaccines (2023) Vol. 11, Iss. 2, pp. 436-436
Open Access | Times Cited: 19
A Century of Clinical Use of Phages: A Literature Review
K. Diallo, A. Dublanchet
Antibiotics (2023) Vol. 12, Iss. 4, pp. 751-751
Open Access | Times Cited: 18
Bacteriophage therapy for human musculoskeletal and skin/soft tissue infections
Willem‐Jan Metsemakers, Jolien Onsea, T. Fintan Moriarty, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 6, pp. 695-701
Open Access | Times Cited: 17
Large-scale genomic survey with deep learning-based method reveals strain-level phage specificity determinants
Yi‐Yan Yang, Keith Dufault‐Thompson, Wei Yan, et al.
GigaScience (2024) Vol. 13
Open Access | Times Cited: 6
Genomic characterization of lytic bacteriophages targeting genetically diverse Pseudomonas aeruginosa clinical isolates
Hayley R. Nordstrom, Daniel R. Evans, Amanda G. Finney, et al.
iScience (2022) Vol. 25, Iss. 6, pp. 104372-104372
Open Access | Times Cited: 26
Clinical phage microbiology: a narrative summary
Gina A. Suh, Robin Patel
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 6, pp. 710-713
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top